# Jiurong Liang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jiurong-liang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,373 |
| Field | Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis |
| h-index | 42 |
| i10-index | 69 |
| Last Known Institution | Cedars-Sinai Medical Center |
| OpenAlex ID | https://openalex.org/A5019095151 |
| ORCID iD | 0000-0001-5179-5016 |
| Works | 112 |

## Researcher papers

- [Regulation of lung injury and repair by Toll-like receptors and hyaluronan](https://scholariq.org/papers/regulation-of-lung-injury-and-repair-by-toll-like-receptors-and-hyaluronan/)
- [Hyaluronan as an Immune Regulator in Human Diseases](https://scholariq.org/papers/hyaluronan-as-an-immune-regulator-in-human-diseases/)
- [Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition](https://scholariq.org/papers/multiple-stromal-populations-contribute-to-pulmonary-fibrosis-without-evidence/)
- [Hyaluronan in Tissue Injury and Repair](https://scholariq.org/papers/hyaluronan-in-tissue-injury-and-repair/)
- [Resolution of Lung Inflammation by CD44](https://scholariq.org/papers/resolution-of-lung-inflammation-by-cd44/)
- [Single-Cell Deconvolution of Fibroblast Heterogeneity in Mouse Pulmonary Fibrosis](https://scholariq.org/papers/single-cell-deconvolution-of-fibroblast-heterogeneity-in-mouse-pulmonary/)
- [Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44](https://scholariq.org/papers/severe-lung-fibrosis-requires-an-invasive-fibroblast-phenotype-regulated-by/)
- [Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells](https://scholariq.org/papers/demonstration-that-mutation-of-the-type-ii-transforming-growth-factor-receptor/)
- [Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis](https://scholariq.org/papers/interleukin-11-is-a-therapeutic-target-in-idiopathic-pulmonary-fibrosis/)
- [Regulation of pulmonary fibrosis by chemokine receptor CXCR3](https://scholariq.org/papers/regulation-of-pulmonary-fibrosis-by-chemokine-receptor-cxcr3/)
- [State of the ART: Drug Screening Reveals Artesunate as a Promising Anti-Fibrosis Therapy](https://scholariq.org/papers/state-of-the-art-drug-screening-reveals-artesunate-as-a-promising-anti-fibrosis/)

## Researcher topics

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Neonatal Respiratory Health Research](https://scholariq.org/topics/neonatal-respiratory-health-research/)
- [Proteoglycans and glycosaminoglycans research](https://scholariq.org/topics/proteoglycans-and-glycosaminoglycans-research/)
- [Medical Imaging and Pathology Studies](https://scholariq.org/topics/medical-imaging-and-pathology-studies/)
- [Immune Response and Inflammation](https://scholariq.org/topics/immune-response-and-inflammation/)

## Researcher university

- [Cedars-Sinai Medical Center](https://scholariq.org/institutions/cedars-sinai-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.